| Authors: |
Conde E; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.; Sorbonne University, ED394, Paris, France.; Neovacs SA, Paris, France., Bertrand R; Neovacs SA, Paris, France., Balbino B; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.; Sorbonne University, ED394, Paris, France., Bonnefoy J; Neovacs SA, Paris, France., Stackowicz J; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.; Sorbonne University, ED394, Paris, France., Caillot N; Neovacs SA, Paris, France., Colaone F; Neovacs SA, Paris, France., Hamdi S; Neovacs SA, Paris, France., Houmadi R; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France., Loste A; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France., Kamphuis JBJ; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France., Huetz F; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France., Guilleminault L; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France.; Department of respiratory medicine, Toulouse University Hospital, Faculty of Medicine, Toulouse, France., Gaudenzio N; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France., Mougel A; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France., Hardy D; Institut Pasteur, Experimental Neuropathology Unit, Paris, France., Snouwaert JN; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Koller BH; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Serra V; Neovacs SA, Paris, France., Bruhns P; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France., Grouard-Vogel G; Neovacs SA, Paris, France., Reber LL; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France. laurent.reber@inserm.fr.; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France. laurent.reber@inserm.fr. |
